Gro for Tissue Therapies
Wednesday, 09 July, 2008
Tissue Therapies [ASX: TIS] is to conduct a clinical trial of its VitroGro wound healing technology in Perth, to begin in August.
The trial will be conducted at UWA Professor Chris Stacey's wound care clinic in Perth, and will concentrate on venous ulcers.
Tissue Therapies is also awaiting regulatory approval to conduct another group of trials in Toronto, Canada, which will concentrate on diabetic and pressure ulcers (bed sores). Preparation for both trials is complete.
VitroGro has already undergone more than six years of laboratory research using live human skin cells. The technology was developed from research at Queensland University of Technology's Institute for Health and Biomedical Innovation (IHBI).
Sunscreen and supplements can lower your vitamin D levels
People who use SPF50+ sunscreen daily are more likely to be vitamin D deficient, while taking...
Low-dose drug prevents diabetes progression in young people
A low dose of the immunomodulatory drug anti-thymocyte globulin (ATG) appears safe and effective...
Mediterranean-style diet benefits maternal and infant health
Two studies have found that a Mediterranean-style diet benefits maternal health during pregnancy...
